【摘要】 用放兔法同步检测急性脑血管病患者（ACVD_s）95例血浆β-TG、TXB₂和6-酮PGF₁α（下简称6-酮）的含量变化。发现ACVD_s血浆β-TG、TXB₂含量增高,而6-酮均降低,与对照组相比有显著差异,并可作为出血性脑血管病（HCVD）和缺血性脑血管病（ICVD）鉴别指标之一。动态观察还发现阿斯匹林（ASA）对降低ICVD的血浆β-TG和TXB₂浓度及改善临床症状、预防缺血性卒中复发有一定价值,而对6-酮则无明显影响。更多还原

【Abstract】 The levels of plasma β-TG, TXB₂ and 6-Keto-PGF_1α were detected simultaneouslyin 95 patients with acute cerebrovascular diseases （ACVDs） by radioimmunoassay. Itwas found that both the plasma β-TG and TXB₂ levels in ACVD₅ increased and 6-Keto-PGF_1α decreased. The difference was very significant when compared with thecontrol group. And the levels of TXB₂ and β-TG could be used as an index indifferentiation between haemorrhagic cerebrovascular diseases （HCVD） and ischemiccerebrovascular diseases （ICVD）. It was also found that ASA had a better effect indecreasing plasma β-TG and TXB₂levels in ICVD, improving clinical manifestations andpreventing the recurrence of ICVD, and no significant influence to 6-Keto-PGF_1α.更多还原